This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Pengyu Xu, Ph.D.
President and Representative Director at SynCrest Inc.


Pengyu Xu obtained his B.S, M.S and Ph. D from the University of Tokyo. Then he joined Otsuka Chemical as a researcher for peptide/oligonucleotide synthesis. Recently, he lead the establishment of SynCrest, a joint venture between Otsuka Chmical and Yokogawa Electrics. He is currently the president and representative director of SynCrest Inc.

Agenda Sessions

  • In-line Monitoring Method Integrating Flow Chemistry for Peptide/Nucleotide Synthesis